Growth Metrics

Edwards Lifesciences (EW) Current Leases (2019 - 2026)

Edwards Lifesciences has reported Current Leases over the past 8 years, most recently at $24.5 million for Q4 2025.

  • For Q4 2025, Current Leases rose 4.7% year-over-year to $24.5 million; the TTM value through Dec 2025 reached $24.5 million, up 4.7%, while the annual FY2025 figure was $24.5 million, 4.7% up from the prior year.
  • Current Leases for Q4 2025 was $24.5 million at Edwards Lifesciences, down from $26.8 million in the prior quarter.
  • Over five years, Current Leases peaked at $26.8 million in Q3 2025 and troughed at $21.5 million in Q2 2024.
  • A 5-year average of $24.4 million and a median of $24.3 million in 2023 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: dropped 11.52% in 2024 and later grew 20.47% in 2025.
  • Year by year, Current Leases stood at $25.5 million in 2021, then changed by 0.0% to $25.5 million in 2022, then dropped by 10.2% to $22.9 million in 2023, then rose by 2.18% to $23.4 million in 2024, then grew by 4.7% to $24.5 million in 2025.
  • Business Quant data shows Current Leases for EW at $24.5 million in Q4 2025, $26.8 million in Q3 2025, and $25.9 million in Q2 2025.